Report summary

The 2021-2023 picture for University of California, San Francisco Department of Pharmaceutical Chemistry is a 34-PI network with 58 internal PI collaborations. The main research signal is Biochemistry, Genetics and Molecular Biology as the leading field (33% of slots across 24 PIs; 24 labels), Molecular Biology as the leading subfield (24% of slots across 21 PIs; 21 labels), and Monoclonal and Polyclonal Antibodies Research as the leading topic (6% of slots across 6 PIs; 6 labels). That is a nice sign for applicants and collaborators, because the network has both density and separable local groups. The leading PI names are James A. Wells (19.1 weighted works; Advanced biosensing and bioanalysis techniques, CAR-T cell therapy research). The clearest collaboration lines are Lani F. Wu and Steven J. Altschuler (14 shared works, weight 7.7). The leading breakdown groups are group 1 with 10 PIs, 10 internal connections, weight 10.2, around Radiology, Nuclear Medicine and Imaging, Molecular Biology, Oncology, led by James A. Wells, Jason E. Gestwicki, Adam R. Renslo; group 2 with 7 PIs, 6 internal connections, weight 15.5, around Molecular Biology, Computational Theory and Mathematics, Epidemiology, led by Brian K. Shoichet, Danica Galonić Fujimori, Steven J. Altschuler.